ReviewSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Advances in the treatment of central serous chorioretinopathy.
Review in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- A comprehensive overview: deep learning approaches to central serous chorioretinopathy diagnosis.BMC ophthalmology · 2025Pooled it
- Spatial Choroidal Analysis under Mid-Phase Hyperfluorescent Plaques Demonstrates Unique Signatures in Central Serous Chorioretinopathy: Macula Society International Central Serous Chorioretinopathy Research Network Report Number 20.Ophthalmology science · 2026Article
- The impact of collaborative pain management by healthcare providers on sleep quality and self-efficacy in perioperative lumbar surgery patients.Scientific reports · 2025Article
- Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025Article
- Quantitative Changes in Vascular and Neural Fibers Induced by Subretinal Fluid Excluding the Peripapillary Region in Patients with Chronic Central Serous Chorioretinopathy.Diagnostics (Basel, Switzerland) · 2025Article
- Acute Central Serous Chorioretinopathy Outbreak during the COVID-19 Pandemic: A Pilot Study.Medicina (Kaunas, Lithuania) · 2024Article
- Review
- Non-damaging retinal laser therapy in chronic central serous chorioretinopathy.International ophthalmology · 2023Article
- Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies.Eye and vision (London, England) · 2023Review
- Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy.Scientific reports · 2023Article
- Pathomechanisms in central serous chorioretinopathy: A recent update.International journal of retina and vitreous · 2023Review
- Funduscopy-guided fluorescein angiography-free focal laser photocoagulation for central serous chorioretinopathy.Indian journal of ophthalmology · 2022Article
- RetFluidNet: Retinal Fluid Segmentation for SD-OCT Images Using Convolutional Neural Network.Journal of digital imaging · 2021Article
- Treatment of central serous chorioretinopathy with topical NSAIDs.Clinical ophthalmology (Auckland, N.Z.) · 2019Article
- The role of OCT-A in retinal disease management.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2018Review
- Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy.Medical hypothesis, discovery & innovation ophthalmology journal · 2018Article
- Spotlight on fundus autofluorescence.Clinical optometry · 2018Review
- Factors affecting the visual outcome in acute central serous chorioretinopathy.Pakistan journal of medical sciencesArticle
- Central serous chorioretinopathy: Treatment.Taiwan journal of ophthalmologyReview
- Effect of half adult dose of oral Rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy.Pakistan journal of medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have identified choroidal dysfunction as the principal element in CSCR development. New imaging tools have aided in better monitoring disease response to various treatment models. Enhanced depth imaging optical coherence tomography, in particular, has helped in observing choroidal thickness changes after various treatment models. To date, photodynamic therapy and focal laser remain the main stay of treatment. More understanding of disease pathophysiology in the future will help in determining the drug of choice and the best management option for such cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.